Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADIPOR2 | Q86V24 | 1/20 | 1.00 |
| ▸ | ADIPOR1 | Q96A54 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 0.83 |
| ▸ | USP2 | O75604 | 1/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.62 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | FAAH | O00519 | 1/20 | 0.58 |
| ▸ | BCHE | P06276 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17950883 | 0.95 | ADIPOR2 (0.90) | ADIPOR2ADIPOR1POLBUSP2SMN1; SMN2 | |
| SCHEMBL17946118 | 0.94 | ADIPOR2 (0.88) | ADIPOR2ADIPOR1POLBUSP2SMN1; SMN2 | |
| SCHEMBL24514564 | 0.90 | ADIPOR2 (0.82) | ADIPOR2ADIPOR1POLBUSP2SMN1; SMN2 | |
| SCHEMBL24514572 | 0.90 | ADIPOR2 (0.81) | ADIPOR2ADIPOR1POLBUSP2SMN1; SMN2 | |
| SCHEMBL24514563 | 0.89 | POLB (0.86) | ADIPOR2ADIPOR1POLBUSP2SMN1; SMN2 | |
| SCHEMBL17946047 | 0.89 | POLB (0.91) | ADIPOR2ADIPOR1POLBUSP2SMN1; SMN2 | |
| SCHEMBL21064273 | 0.88 | ADIPOR2 (0.78) | ADIPOR2ADIPOR1POLBUSP2SMN1; SMN2 | |
| SCHEMBL25568932 | 0.88 | ADIPOR2 (0.77) | ADIPOR2ADIPOR1POLBUSP2SMN1; SMN2 | |
| SCHEMBL17945987 | 0.88 | POLB (0.84) | ADIPOR2ADIPOR1POLBUSP2SMN1; SMN2 | |
| SCHEMBL20662532 | 0.87 | ADIPOR2 (0.77) | ADIPOR2ADIPOR1POLBUSP2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295678-A1 | ULTRA LOW DOSAGE ZOLEDRONIC ACID FOR TREATMENT OF RETINAL DISEASE | THE WISCONSIN ALUMNI RESEARCH FOUNDATION | 2025-09-25 | — | — | US | claimed |
| CN-120189494-A | Use of adiponectin and adiponectin receptor agonists for the treatment of amyotrophic lateral sclerosis | 河北医科大学第二医院 | 2025-06-24 | — | — | CN | claimed |
| EP-4522177-A1 | ULTRA LOW DOSAGE ZOLEDRONIC ACID FOR TREATMENT OF RETINAL DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-03-19 | — | — | EP | claimed |
| US-20240288450-A1 | SYSTEMS AND METHODS FOR MONITORING AND TREATING STROKE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-08-29 | — | — | US | claimed |
| US-20240016788-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC AND POSTMENOPAUSAL OSTEOPOROSIS, CONTAINING ADIPORON | PNP BIOPHARM CO LTD (KR) | 2024-01-18 | — | — | US | claimed |
| CN-117337167-A | Compositions and methods relating to hair loss | 阿拉斯廷护肤品股份有限公司 | 2024-01-02 | — | — | CN | claimed |
| EP-4294533-A1 | COMPOSITIONS AND METHODS RELATING TO ALOPECIA | Alastin Skincare, Inc. (US) | 2023-12-27 | — | — | EP | claimed |
| US-20230390355-A1 | COMPOSITIONS AND METHODS RELATING TO ALOPECIA | ALASTIN Skincare, Inc. (US) | 2023-12-07 | — | — | US | claimed |
| WO-2023220136-A1 | ULTRA LOW DOSAGE ZOLEDRONIC ACID FOR TREATMENT OF RETINAL DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-11-16 | — | — | WO | claimed |
| CN-116622628-A | Serum-free culture medium for producing exosomes by mesenchymal stem cells, and preparation and application thereof | 华东理工大学 | 2023-08-22 | — | — | CN | claimed |
| WO-2022266039-A1 | SYSTEMS AND METHODS FOR MONITORING AND TREATING STROKE | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-12-22 | — | — | WO | claimed |
| CN-115245512-A | Method for intervening oxidative stress of oral active AdipoRon on liver of type II diabetic mouse | 温州医科大学 | 2022-10-28 | — | — | CN | claimed |
| WO-2022177881-A1 | COMPOSITIONS AND METHODS RELATING TO ALOPECIA | ALASTIN Skincare, Inc. (US) | 2022-08-25 | — | — | WO | claimed |
| US-20220249458-A1 | Agonists Of Adiponectin | BAYER AKTIENGESELLSCHAFT (DE) | 2022-08-11 | — | — | US | claimed |
| WO-2022103197-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC AND POSTMENOPAUSAL OSTEOPOROSIS, CONTAINING ADIPORON | (주)피앤피바이오팜 | 2022-05-19 | — | — | WO | claimed |
| CN-114073667-A | Methods and systems for treating obesity-related diseases with orally active adiplon | 温州医科大学 | 2022-02-22 | — | — | CN | claimed |
| EP-3946416-A2 | AGONISTS OF ADIPONECTIN | Bayer Aktiengesellschaft (DE) | 2022-02-09 | — | — | EP | claimed |
| EP-3431468-B1 | USE OF ADIPONECTIN RECEPTOR AGONISTS IN TREATING DEPRESSION, ANXIETY AND NEUROINFLAMMATION | CENTRE NAT RECH SCIENT (FR) | 2021-06-09 | — | — | EP | claimed |
| WO-2020201195-A2 | AGONISTS OF ADIPONECTIN | BAYER AKTIENGESELLSCHAFT (DE) | 2020-10-08 | — | — | WO | claimed |
| EP-3431468-A1 | USE OF ADIPONECTIN RECEPTOR AGONISTS IN TREATING DEPRESSION, ANXIETY AND NEUROINFLAMMATION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-01-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295678-A1 | ULTRA LOW DOSAGE ZOLEDRONIC ACID FOR TREATMENT OF RETINAL DISEASE | FDPS, SMPD1, SMPD2 | ADIPOR2 566/4885ADIPOR1 362/4885POLB 3643/4885 |
| US-20220249458-A1 | Agonists Of Adiponectin | ADIPOR1, ADIPOR2, FABP4 | ADIPOR2 2/4885ADIPOR1 1/4885POLB 4727/4885 |
| US-20240016788-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC AND POSTMENOPAUSAL OSTEOPOROSIS, CONTAINING ADIPORON | ADIPOR1, ADIPOR2, PPARA | ADIPOR2 2/4885ADIPOR1 1/4885POLB 3567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.